Island Pharmaceuticals inks US Army research deal to advance Marburg antiviral program

Impact · against what's priced in

Island Pharmaceuticals receives a catalyst through a formal three-year research agreement with USAMRIID to pursue the FDA's Animal Rule pathway for Marburg virus. The partnership provides institutional validation and a defined regulatory roadmap, reducing execution risk for galidesivir.

ILA+0.60

No priced-in read yet